iodoacetamide has been researched along with Leukemia L 1210 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noda, Y | 1 |
| Kawazoe, Y | 1 |
| Hakura, A | 1 |
| Kruczynski, A | 1 |
| Barret, JM | 1 |
| Etiévant, C | 1 |
| Colpaert, F | 1 |
| Fahy, J | 1 |
| Hill, BT | 1 |
| Prager, MD | 1 |
| Gordon, WC | 1 |
| Baechtel, FS | 1 |
| Duffy, TH | 1 |
| Sato, JK | 1 |
| Vitols, KS | 1 |
| Huennekens, FM | 1 |
4 other studies available for iodoacetamide and Leukemia L 1210
| Article | Year |
|---|---|
Cytotoxicity of naphthoquinones toward cultured resting murine leukemia L1210 cells in the presence of glutathione, diethyl maleate, or iodoacetamide.
Topics: Alkylating Agents; Animals; Cell Survival; Culture Media; Drug Interactions; Glutathione; Iodoacetam | 1997 |
Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Topics: Alkylation; Animals; Antineoplastic Agents, Phytogenic; Cell Cycle; Cells, Cultured; Guanosine Triph | 1998 |
Immunogenicity of modified tumor cells in syngenic hosts.
Topics: Animals; Antibodies, Neoplasm; Antibody Specificity; Ascitic Fluid; Asparaginase; Immunity, Cellular | 1976 |
L1210 dihydrofolate reductase: activation and enhancement of methotrexate sensitivity.
Topics: Animals; Dithionitrobenzoic Acid; Electrophoresis, Agar Gel; Enzyme Activation; Folic Acid Antagonis | 1985 |